
Contact us
About company
We have identified, and are developing a highly differentiated, novel protein therapeutic (Acerbin) to treat eating disorders and obesity by directly impacting the palatability of food, thereby reducing hedonic eating (eating for pleasure), without impacting eating for sustenance.
US 10210 campus point drive
Unknown
Not verified company